ArticlePediatric cardiology2026

Nasal Nitric Oxide as a Novel Biomarker for Assessing Risk of Impaired Neurodevelopment in Infants and Newborns with Congenital Heart Disease.

Emma Powers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.